Nadine Barrett

Overview:

Dr, Nadine J. Barrett is an Assistant Professor in the Department of Family Medicine and Community Health at Duke University. She currently hold senior leadership roles as CTSI Co-Director for Equity and Stakeholder Strategy and the Inaugural Director of The Center for Equity in Research in the Duke Clinical Translational Science Institute, and Associate Director for Equity and Stakeholder Strategy, Duke Cancer Institute. A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally-recognized leader in facilitating community/stakeholder and academic partnerships to advance health equity and developing training and methods to address implicit bias and structural and systemic racism that limits diverse participation in biomedical research. Her goals are to integrate diverse stakeholder engagement in the research process and healthcare systems, enhance enrollment and retention of underrepresented groups in biomedical research, increase diversity in the research workforce, and advance health equity. Prior to her current role, Dr. Barrett was the inaugural director of the Duke Cancer Institute’s Office of Health Equity, where for eight years she led a team to create a nationally awarded community engagement model to advance health equity, through patient navigation, nationally funded pipeline training programs for underrepresented race and ethnic groups, and authentic community partnerships to inform and drive research and quality healthcare as advisors, experts, and participants. Her leadership in both nonprofit and academia spans local, national, and international partnerships to better serve and engage historically marginalized and underserved populations.



Positions:

Assistant Professor in Family Medicine and Community Health

Family Medicine and Community Health, Community Health
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

Ph.D. 2005

Texas Woman's University

Grants:

Just Ask - Increasing Diversity in Oncology Clinical Research and Trials An Institutional and Stakeholder Engagement Approach

Administered By
Duke Cancer Institute
Awarded By
V Foundation for Cancer Research
Role
Principal Investigator
Start Date
End Date

Lung Cancer Screening Initiative

Administered By
Duke Cancer Institute
Awarded By
Lung Cancer Initiative of North Carolina
Role
Principal Investigator
Start Date
End Date

Breast Cancer Awareness to Action Ambassador Program (BCAAAP)

Administered By
Duke Cancer Institute
Awarded By
Susan G Komen for the Cure
Role
Principal Investigator
Start Date
End Date

JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease

Administered By
Duke Molecular Physiology Institute
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date

JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease

Administered By
Medicine, Nephrology
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date

Publications:

The 5Ws of Racial Equity in Research: A Framework for Applying a Racial Equity Lens Throughout the Research Process

Authors
Bentley-Edwards, KL; Jordan Fleming, P; Doherty, IA; Whicker, DR; Mervin-Blake, S; Barrett, NJ
MLA Citation
Bentley-Edwards, Keisha L., et al. “The 5Ws of Racial Equity in Research: A Framework for Applying a Racial Equity Lens Throughout the Research Process.” Health Equity, vol. 6, no. 1, Mary Ann Liebert Inc, Dec. 2022, pp. 917–21. Crossref, doi:10.1089/heq.2022.0042.
URI
https://scholars.duke.edu/individual/pub1559955
Source
crossref
Published In
Health Equity
Volume
6
Published Date
Start Page
917
End Page
921
DOI
10.1089/heq.2022.0042

Association and Causation Without Adequate Representation: An Evaluation of the Reporting of Race and Ethnicity of Study Participants in Hospice and Palliative Medicine Research

Authors
Rhodes, R; Ejem, D; Barrett, N; Preston, A; Smith, C; Bullock, K; Bethea, K; Hasan, M; Johnson, K
MLA Citation
URI
https://scholars.duke.edu/individual/pub1524564
Source
wos-lite
Published In
Journal of Pain and Symptom Management
Volume
63
Published Date
Start Page
1140
End Page
1140

Racial Differences in Advance Care Planning and Preferences for End-of-Life Care: Has COVID-19 Changed Anything?

Authors
Gangavati, A; Olsen, M; Ejem, D; Rhodes, R; Dolor, R; Durant, R; Bodiford, D; Barrett, N; Williams, S; Thorne, G; Bethea, K; Johnson, K; Ruffin, F
MLA Citation
Gangavati, Anupama, et al. “Racial Differences in Advance Care Planning and Preferences for End-of-Life Care: Has COVID-19 Changed Anything?Journal of Pain and Symptom Management, vol. 63, no. 6, 2022, pp. 1073–74.
URI
https://scholars.duke.edu/individual/pub1524871
Source
wos-lite
Published In
Journal of Pain and Symptom Management
Volume
63
Published Date
Start Page
1073
End Page
1074

Assessing feasibility and utility of an implicit bias training program for addressing disparities in cancer clinical trial participation.

Authors
Barrett, N; Boehmer, L; Schrag, J; Benson, AB; Green, S; Hamroun, L; Howson, A; Matin, K; Oyer, RA; Pierce, LJ; Jeames, SE; Winkfield, KM; Yang, ES-H; Zwicker, V; Bruinooge, SS; Hurley, PA; Williams, JHH; Guerra, C
MLA Citation
Barrett, Nadine, et al. “Assessing feasibility and utility of an implicit bias training program for addressing disparities in cancer clinical trial participation.Journal of Clinical Oncology, vol. 40, no. 16, 2022, pp. E18599–E18599.
URI
https://scholars.duke.edu/individual/pub1556208
Source
wos-lite
Published In
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Volume
40
Published Date
Start Page
E18599
End Page
E18599

Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment.

BACKGROUND: We sought to identify modifiable factors associated with cancer screening in a community-based health assessment. METHODS: 24 organizations at 47 community events in central North Carolina distributed a 91-item survey from April-December 2017. Responses about (1) interest in disease prevention, (2) lifestyle choices (e.g., diet, tobacco), and (3) perceptions of primary care access/quality were abstracted to examine their association with self-reported screening participation and knowledge about breast, prostate, and colorectal cancer. RESULTS: 2135/2315 participants (92%; 38.5% White, 38% Black, 9.9% Asian) completed screening questions. >70% of screen-eligible respondents reported guideline-concordant screening. Healthy dietary habits were associated with greater knowledge about breast and colorectal cancer screening; reporting negative attitudes about and barriers to healthcare were associated with less breast, prostate, and colorectal cancer screening. Having a place to seek medical care (a proxy for primary care access) was independently associated with being ∼5 times as likely to undergo colorectal screening (OR 4.66, 95% CI 1.58-13.79, all p < 0.05). CONCLUSIONS: In this diverse, community-based sample, modifiable factors were associated with screening engagement, highlighting opportunities for behavioral intervention.
Authors
MLA Citation
Fayanju, Oluwadamilola M., et al. “Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment.Am J Surg, Nov. 2022. Pubmed, doi:10.1016/j.amjsurg.2022.10.059.
URI
https://scholars.duke.edu/individual/pub1555407
PMID
36411107
Source
pubmed
Published In
Am J Surg
Published Date
DOI
10.1016/j.amjsurg.2022.10.059